Key result
In female mice, VPAC1 receptors play a dominant role in PACAP-induced vasorelaxation in both carotid and femoral arteries, with PACAP knockout mice showing reduced relaxation only in carotid arteries.
Why the study?
While vasomotor activity of PACAP was previously reported in male mice, female vascular responses remained unexplored.
VPAC1 receptors mediate PACAP-induced vasorelaxation in female mice, with regional differences in receptor availability observed in PACAP-deficient mice.
Answers are grounded in this paper and cite their sources.
Cannot yet guide human therapy; extends evidence on VPAC1 dominance in murine arteries but leaves open clinical relevance.
BACKGROUND: PACAP and VIP are closely related neuropeptides with wide distribution and potent effect in the vasculature. We previously reported vasomotor activity in peripheral vasculature of male wild type (WT) and PACAP-deficient (KO) mice. However, female vascular responses are still unexplored. We hypothesized that PACAP-like activity is maintained in female PACAP KO mice and the mechanism through which it is regulated differs from that of male PACAP KO animals. METHODS: We investigated the vasomotor effects of VIP and PACAP isoforms and their selective blockers in WT and PACAP KO female mice in carotid and femoral arteries. The expression and level of different PACAP receptors in the vessels were measured by RT-PCR and Western blot. RESULTS: In both carotid and femoral arteries of WT mice, PACAP1-38, PACAP1-27 or VIP induced relaxation, without pronounced differences between them. Reduced relaxation was recorded only in the carotid arteries of KO mice as compared to their WT controls. The specific VPAC1R antagonist completely blocked the PACAP/VIP-induced relaxation in both arteries of all mice, while PAC1R antagonist affected relaxation only in their femoral arteries. CONCLUSION: In female WT mice, VPAC1 receptors appear to play a dominant role in PACAP-induced vasorelaxation both in carotid and in femoral arteries. In the PACAP KO group PAC1R activation exerts vasorelaxation in the femoral arteries but in carotid arteries there is no significant effect of the activation of this receptor. In the background of this regional difference, decreased PAC1R and increased VPAC1R availability in the carotid arteries was found.
No takes yet. Share an insight, caveat, or question.
Ivić et al. (2019) studied this question. PACAP1-38, PACAP1-27, and VIP vs. Wild-type mice was evaluated on Vasorelaxation in carotid and femoral arteries. In female mice, VPAC1 receptors play a dominant role in PACAP-induced vasorelaxation in both carotid and femoral arteries, with PACAP knockout mice showing reduced relaxation only in carotid arteries.
Synapse has enriched 10 related papers. Consider them for comparative context: